Filing Details
- Accession Number:
- 0001144204-11-016455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-22 18:26:47
- Reporting Period:
- 2011-03-22
- Filing Date:
- 2011-03-22
- Accepted Time:
- 2011-03-22 18:26:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319874 | M Joseph Feczko | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue, 20Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-22 | 20,000 | $4.34 | 25,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price. The range of prices for such transactions is $4.34 to $4.35. The reporting person effected multiple same-way open market sales transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Of the 25,000 shares, 5,000 are shares of restricted stock.
Billionaire Hedge Funds
